Senior insider sale
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$851.6K
46.49K shares
What this filing means
ACCARDI MARIO ALBERTO plans to sell 46.49K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $851.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/27/2025ACC: 0001969223-25-000877
DirectorOfficer· Chief Executive Officer
Since Feb 2026
46.49K
Shares to sell
$851.6K
Approx. market value
8K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Founders Shares
NA
1/2/2020
8KTotal acquired8K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2020 | Founders Shares NA | 8K | — |
| Total | 8K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
8.17K
Market value
$174.8K
9/16/2025
—Completed
Units to sell
7K
Market value
$140.0K
9/9/2025
—Completed
Units to sell
8.32K
Market value
$126.8K
7/29/2025
—Completed
Units to sell
15K
Market value
$210.0K
6/24/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
8K
Market value
$200.0K
10/27/2025
Total
Units
46.49K
Value
$851.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2025 | 8.17K | $174.8K | — | Completed |
9/9/2025 | 7K | $140.0K | — | Completed |
7/29/2025 | 8.32K | $126.8K | — | Completed |
6/24/2025 | 15K | $210.0K | — | Completed |
| Planned — Approximate Date | ||||
10/27/2025 | 8K | $200.0K | Nasdaq | Planned |
| Total | 46.49K | $851.6K | ||